Sign in

CIK 0001372514

  • Non-accelerated filer
  • Smaller reporting company

KIORA PHARMACEUTICALS INC

Sign in to watch
Tickers
KPRX KPHMW
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
980443284
Phone
+1 858-224-9600
Business address
169 SAXONY RD., SUITE 212, ENCINITAS, CA, 92024
Former names
EYEGATE PHARMACEUTICALS INC

Securities

  • KPRX Common Stock Nasdaq
  • KPHMW Common stock OTC
  1. 4 Shares withheld for taxes President and CEO gave up 670 shares (to pay taxes)
  2. 4 Shares withheld for taxes VP of Engineering gave up 122 shares (to pay taxes)
  3. 4 Shares withheld for taxes Chief Financial Officer gave up 122 shares (to pay taxes)
  4. 4 Shares withheld for taxes President and CEO gave up 712 shares (to pay taxes)
  5. 4 Shares withheld for taxes VP of Research & Development gave up 130 shares (to pay taxes)
  6. 4 Shares withheld for taxes VP of Engineering gave up 130 shares (to pay taxes)
  7. 4 Shares withheld for taxes Chief Financial Officer gave up 130 shares (to pay taxes)
  8. 4 Grant or award President and CEO acquired 20,000 shares (grant or award)
  9. 4 Grant or award Chief Financial Officer acquired 10,000 shares (grant or award)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Grant or award VP of Engineering acquired 7,500 shares (grant or award)
  15. 4 Grant or award VP of Research & Development acquired 7,500 shares (grant or award)
  16. 4 Derivatives Options or other derivatives
  17. 4 Open-market buy Director bought 23,000 shares at an average $6.11 ($140,460)
  18. 4 Shares withheld for taxes President and CEO gave up 584 shares (to pay taxes)
  19. 4 Shares withheld for taxes VP of Engineering gave up 109 shares (to pay taxes)
  20. 4 Shares withheld for taxes VP of Research & Development gave up 109 shares (to pay taxes)

Page 10 of 21 · 406 filings